Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04UKP
|
|||
| Former ID |
DIB013257
|
|||
| Drug Name |
Tenatumomab
|
|||
| Synonyms |
ST-1897; ST-2146; PAGRIT (cancer), Sigma-Tau; Pretargeted antibody-guided radioimmunotherapy, Sigma-Tau; Anti-tenascin antibodies (cancer), Sigma-Tau
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 3 | [1] | |
| Company |
Sigma-Tau SpA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Ann Oncol. 2014 Jul;25(7):1346-55. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.